Roche released detailed data at the European Hematology Association congress for its CD20xCD3 bispecific antibody Columvi in earlier lines of large B cell lymphoma, showing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.